CORT

Corcept Therapeutics
CORT

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$7.31B
EV
$6.71B
Shares Outstanding
123.69M
Beta
0.15

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$143.25
P/E 2025E
40.87x
P/Revenue 2025E
8.07x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Corcept Therapeutics Incorporated

gainify
CORT

Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia seco...

Sector

Healthcare

Industry

Biotechnology

CEO

Belanoff, Joseph

Employees

500

IPO Date

2004-04-14

Headquarters

149 Commonwealth Drive, Menlo Park, California, 94025, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved